Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation
Anna Więckowska, Marcin Kołaczkowski, Adam Bucki, et al.
European Journal of Medicinal Chemistry (2016) Vol. 124, pp. 63-81
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Chuang Zhao, K.P. Rakesh, L. Ravidar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 162, pp. 679-734
Open Access | Times Cited: 482
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, et al.
Progress in Neurobiology (2018) Vol. 174, pp. 53-89
Closed Access | Times Cited: 285
Sulfonamide derivatives as multi-target agents for complex diseases
Sinem Apaydın, Marianna Török
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 16, pp. 2042-2050
Closed Access | Times Cited: 200
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents
Elisabetta Barresi, Emma Baglini, Valeria Poggetti, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2127-2127
Open Access | Times Cited: 17
Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease
Deepti Goyal, Amandeep Kaur, Bhupesh Goyal
ChemMedChem (2018) Vol. 13, Iss. 13, pp. 1275-1299
Open Access | Times Cited: 135
From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology
Claudia Albertini, Alessandra Salerno, Pedro de Sena Murteira Pinheiro, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 5, pp. 2606-2633
Closed Access | Times Cited: 129
Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status
Hilda Ferrero, Maite Solas, Paul T. Francis, et al.
CNS Drugs (2016) Vol. 31, Iss. 1, pp. 19-32
Closed Access | Times Cited: 93
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 46
Tacrine-Based Hybrids: Past, Present, and Future
Anna Bubley, Alexander S. Erofeev, Peter Gorelkin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1717-1717
Open Access | Times Cited: 24
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
Najmeh Oliyaei, Marzieh Moosavi‐Nasab, Nader Tanideh, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 11-21
Open Access | Times Cited: 38
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
Jie Zhu, Hongyu Yang, Yao Chen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 496-506
Open Access | Times Cited: 59
Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease
Anna Więckowska, Tomasz Wichur, Justyna Godyń, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 5, pp. 1195-1214
Closed Access | Times Cited: 52
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease
Tomasz Wichur, Anna Więckowska, Krzysztof Więckowski, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111916-111916
Closed Access | Times Cited: 48
The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020
Rzgar Tawfeeq Kareem, Fahimeh Abedinifar, Evan Abdolkareem Mahmood, et al.
RSC Advances (2021) Vol. 11, Iss. 49, pp. 30781-30797
Open Access | Times Cited: 38
Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
Mireia Toledano‐Pinedo, Alicia Porro-Pérez, Linda Schäker‐Hübner, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 5
Modulating 5-Ht 4 and 5-Ht 6 Receptors in Alzheimer’S Disease Treatment
Julien Lalut, Delphine Karila, Patrick Dallemagne, et al.
Future Medicinal Chemistry (2017) Vol. 9, Iss. 8, pp. 781-795
Closed Access | Times Cited: 48
Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii
Yu‐Ming Liu, Yadong Feng, Xi Lin Lu, et al.
European Journal of Medicinal Chemistry (2017) Vol. 137, pp. 280-291
Closed Access | Times Cited: 45
Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse hippocampus
Yong‐Hyun Ko, Seung‐Hwan Kwon, Seok‐Yong Lee, et al.
Archives of Pharmacal Research (2017) Vol. 40, Iss. 10, pp. 1209-1217
Closed Access | Times Cited: 45
Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer’s disease
Hanan M. Ragab, Mohamed Teleb, Hassan R. Haidar, et al.
Bioorganic Chemistry (2019) Vol. 86, pp. 557-568
Closed Access | Times Cited: 40
Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands
Diego A. Rodríguez‐Soacha, Matthias Scheiner, Michael Decker
European Journal of Medicinal Chemistry (2019) Vol. 180, pp. 690-706
Closed Access | Times Cited: 36
Sulfur-containing therapeutics in the treatment of Alzheimer’s disease
Haizhou Zhu, Venkateshwara Dronamraju, Wei Xie, et al.
Medicinal Chemistry Research (2021) Vol. 30, Iss. 2, pp. 305-352
Open Access | Times Cited: 31
Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease
Rakesh Kumar, Vinod Kumar, Bhupinder Kumar, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 10, pp. 1757-1803
Closed Access | Times Cited: 30
Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
Paloma Mayo, Jorge Pascual-Guerra, Enrique Crisman, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2367-2419
Open Access | Times Cited: 4
Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)
Ning Wang, Panpan Qiu, Wei Cui, et al.
Current Medicinal Chemistry (2018) Vol. 26, Iss. 30, pp. 5684-5710
Closed Access | Times Cited: 38
Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
Fang Ma, Hongtao Du
European Journal of Medicinal Chemistry (2017) Vol. 140, pp. 118-127
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top